Short answer · Medically reviewed summary · Last updated: 2026-05-08
Trimethylaminuria is officially classified under the ICD-10 coding system as E88.89 (Other specified metabolic disorders). While the older ICD-9 coding system utilized 277.8 (Other specified disorders of metabolism), medical providers now exclusively use the ICD-10 or the updated ICD-11 (5C51.Y) for clinical documentation and insurance billing purposes. What is the clinical classification of Trimethylaminuria? Trimethylaminuria, often referred to as "fish odor syndrome," is a rare metabolic disorder characterized by the body's inability to oxidize trimethylamine, a compound produced during the digestion of certain foods.
Trimethylaminuria is officially classified under the ICD-10 coding system as E88.89 (Other specified metabolic disorders). While the older ICD-9 coding system utilized 277.8 (Other specified disorders of metabolism), medical providers now exclusively use the ICD-10 or the updated ICD-11 (5C51.Y) for clinical documentation and insurance billing purposes.
Trimethylaminuria, often referred to as "fish odor syndrome," is a rare metabolic disorder characterized by the body's inability to oxidize trimethylamine, a compound produced during the digestion of certain foods. Because Trimethylaminuria is a metabolic condition, it is categorized within broader metabolic disorder codes in standard diagnostic manuals used by clinicians globally.
Individuals with Trimethylaminuria lack sufficient activity of the enzyme flavin-containing monooxygenase 3 (FMO3). When this enzyme is deficient, the body cannot break down trimethylamine, leading to its accumulation and subsequent release through sweat, urine, and breath. The 34 members of our DiseaseMaps community who live with Trimethylaminuria often report that the resulting odor can cause significant social and psychological distress, highlighting the need for both clinical management and emotional support.
Yes, Trimethylaminuria is typically inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of a mutated FMO3 gene (one from each parent) to manifest the primary form of the condition. Genetic testing is the gold standard for confirming the diagnosis, as specific mutations can influence the severity of the metabolic impairment.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.